carnitine and carboplatin

carnitine has been researched along with carboplatin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abd-Allah, AR; Al-Majed, AA; Al-Shabana, OA; Al-Yahya, AA; Fouda, SI1
Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A1
Arafa, HM1
Haschke, M; Herrmann, R; Krähenbühl, S; Lüde, S; Novakova, K; Todesco, L; Vitins, T1
Chang, CC; Chou, HC; Chou, Y; Juan, SH; Sue, YM; Yang, NJ1

Trials

1 trial(s) available for carnitine and carboplatin

ArticleYear
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
    Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1

    Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine

2007

Other Studies

4 other study(ies) available for carnitine and carboplatin

ArticleYear
L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC).
    Archives of toxicology, 2005, Volume: 79, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carboplatin; Carnitine; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Glutathione; Granulocytes; Macrophages; Male; Malondialdehyde; Rats; Rats, Wistar

2005
Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids.
    Toxicology, 2008, Dec-05, Volume: 254, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Blood Urea Nitrogen; Carboplatin; Carnitine; Creatinine; Inflammation; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxidants; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2008
Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carboplatin; Carnitine; Cells, Cultured; Cisplatin; Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Organic Cation Transport Proteins; Organoplatinum Compounds; Oxaliplatin; Solute Carrier Family 22 Member 5

2010
L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Apoptosis; Carboplatin; Carnitine; Cyclooxygenase 2; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Inflammation; Kidney; Mice; NFATC Transcription Factors; PPAR alpha; Protective Agents; Rats; Reactive Oxygen Species; Signal Transduction

2014